MedTrace Logo

GANGlion Stellate Block for Treatment of Electric storRm (GANGSTER Trial)

NCT05078684 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-10-19

No results posted yet for this study

Summary

This study will evaluate the acute effect of ultrasound-navigated left ganglion stellate block to suppress ventricular arrhythmia in patients with arrhythmic storm.

Conditions

  • Ventricular Arrythmia
  • Ventricular Tachycardia
  • Ventricular Fibrillation
  • Arrhythmic Storm
  • Block

Interventions

PROCEDURE

Left ganglion stellate block

Ultrasound-guided anesthetic block of left ganglion stellate using 8ml of 5% bupivacaine.

PROCEDURE

Sham left ganglion stellate block

Subcutaneous application of 0.5-1ml of 5% bupivacaine to the site of expected LGSB

Sponsors & Collaborators

  • Institute for Clinical and Experimental Medicine

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-21
Primary Completion
2024-12-31
Completion
2025-01-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05078684 on ClinicalTrials.gov